BSV Bioscience Philippines Inc. Pharmaceutical Import Profile — Philippines (DGFT 2022–2026)

Name: BSV Bioscience Philippines Inc. Pharmaceutical Import Records from India — 3 Products, $900.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

BSV Bioscience Philippines Inc. — Pharmaceutical Importer Profile (2026) | 3 Products, $900.0K Trade | TransData Nexus

BSV Bioscience Philippines Inc.

Pharmaceutical Importer · Philippines · Antifungals Focus · $900.0K Total Trade · DGFT Verified

BSV Bioscience Philippines Inc. is a pharmaceutical importer based in Philippines with a total trade value of $900.0K across 3 products in 2 therapeutic categories. Based on 18 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. BSV Bioscience Philippines Inc. sources from 1 verified Indian supplier, with Bharat Serums And Vaccines Limited accounting for 100.0% of imports.

BSV Bioscience Philippines Inc. — Import Portfolio & Supplier Network

BSV Bioscience Philippines Inc. import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to BSV Bioscience Philippines Inc.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Bharat Serums And Vaccines Limited	$2.2M	65	100.0%

BSV Bioscience Philippines Inc. sources from 1 verified Indian supplier across 45 distinct formulations. The sourcing is highly concentrated — Bharat Serums And Vaccines Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Ampholip 50MG amphotericin b lipid	$200.0K	4
Gamma iv 5 GM normal immunoglobulin forintravenous use (human	$150.0K	3
Poly-mxb 500,000 unit (lyophilized)[polymyxin b for injection	$150.0K	3
Gamma iv 5 GM [normal immunoglobulin forintravenous use (human	$100.0K	2
Evafact (dienogest tablets 2MG) (2 strips x 14 tabs)	$100.0K	2
Luprodex 11.25 MG leuprolide acetate for injection 11.25 MG	$97.7K	2
Asporelix 0.25 (lyophilized) cetrorelixacetate for injection	$88.6K	3
Ampholip 50MG [amphotericin b lipid	$50.0K	1
Poly-mxb 5,00,000 unit (lyophilized)	$50.0K	1
Luprodex 3.75 (depot) leuprolide	$50.0K	1
Gamma iv 5 GM [normal immunoglobulin	$50.0K	1
Poly-mxb 500,000 unit (lyophilized) [polymyxin b for injection	$50.0K	1
Amphonex 50MG (lyophilized) [liposomal amphotericin b	$50.0K	1
Ampholip 50MG [amphotericin b lipid complex]# [Pack size : 10ML x	$50.0K	1
Luprodex 11.25 MG [leuprolide acetate for injection 11.25 MG)	$50.0K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Amphotericin	Antifungals	$450.0K	9	0.5%	17
2	Immunoglobulin	Other	$250.0K	5	0.1%	19
3	Serum	Other	$200.0K	4	0.7%	16

BSV Bioscience Philippines Inc. imports 3 pharmaceutical products across 2 categories into Philippines totaling $900.0K.

BSV Bioscience Philippines Inc. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

BSV Bioscience Philippines Inc. is a pharmaceutical importer and wholesaler headquartered in Pasig City, Metro Manila, Philippines. Established in 2007, the company is a subsidiary of Bharat Serums and Vaccines Limited, an Indian biopharmaceutical firm founded in 1971. BSV Bioscience Philippines Inc. specializes in importing and distributing life-saving and life-enhancing medicines, with a particular focus on women's health, throughout the Philippines. (philjobnet.gov.ph)

The company's mission, "Bringing Life to Life," underscores its commitment to providing quality, efficacious, safe, and affordable medicines to Filipinos. BSV Bioscience Philippines Inc. has established a solid reputation for excellence and reliability in the market, with its products being used by major hospitals nationwide. (philjobnet.gov.ph)

2Distribution Network

BSV Bioscience Philippines Inc. operates from its main office located at Unit 1002, 10th Floor Exquadra Tower, No. 1 Jade Drive, Ortigas Center, Brgy. San Antonio, Pasig, Metro Manila. (verification.fda.gov.ph) While specific details about its warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic location in Metro Manila suggests a well-established distribution network capable of serving the entire Philippine archipelago. The proximity to major ports and transportation hubs facilitates efficient importation and distribution processes.

3Industry Role

BSV Bioscience Philippines Inc. functions primarily as a pharmaceutical importer and wholesaler within the Philippine pharmaceutical supply chain. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company plays a crucial role in ensuring the availability of essential medicines in the local market. Its focus on importing life-saving and life-enhancing products positions it as a key player in the distribution of critical healthcare solutions across the Philippines.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — BSV Bioscience Philippines Inc.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

BSV Bioscience Philippines Inc. demonstrates a high degree of supplier concentration, sourcing all its pharmaceutical imports from a single supplier: Bharat Serums and Vaccines Limited. This exclusive sourcing strategy indicates a deep-rooted partnership, potentially offering benefits such as favorable pricing, consistent product quality, and reliable supply chains. However, this single-source dependency also introduces risks, including vulnerability to supply disruptions or changes in the supplier's operational status. The company's 18 shipments from this sole supplier reflect a stable and ongoing relationship, suggesting effective collaboration and mutual trust.

2Supply Chain Resilience

The resilience of BSV Bioscience Philippines Inc.'s supply chain is closely tied to its exclusive reliance on Bharat Serums and Vaccines Limited. While this singular sourcing approach may streamline operations, it also exposes the company to potential risks associated with supply chain disruptions, such as production delays or geopolitical issues affecting the supplier. The lack of publicly available information regarding backup suppliers or alternative sourcing strategies further underscores the need for BSV Bioscience Philippines Inc. to develop contingency plans to mitigate potential supply chain vulnerabilities.

Strategic Implications

Importing Pharmaceuticals into Philippines — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Philippines

1Regulatory Authority & Framework

In the Philippines, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation, registration, and distribution of pharmaceutical products. The FDA's mandate includes ensuring the safety, efficacy, and quality of health products available in the market. Key legislation governing pharmaceutical imports includes the Food, Drugs, and Devices Act (Republic Act No. 3720) and the FDA Act of 2009 (Republic Act No. 9711), which provide the legal framework for the regulation of health products in the country. (respicio.ph)

2Import Licensing & GMP

Import licensing requirements in the Philippines stipulate that all pharmaceutical importers must obtain a valid License to Operate (LTO) from the FDA. This license authorizes entities to import and distribute pharmaceutical products within the country. Additionally, the FDA requires that manufacturers of imported pharmaceutical products hold a valid Certificate of Good Manufacturing Practice (GMP) Compliance, ensuring that products meet internationally recognized quality standards. BSV Bioscience Philippines Inc. holds an active LTO, reflecting its compliance with these regulatory requirements. (verification.fda.gov.ph)

Quality & Labeling

BSV Bioscience Philippines Inc. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

BSV Bioscience Philippines Inc. focuses on importing pharmaceutical products across two therapeutic categories: antifungals and other medications. The company's top three imported products—amphotericin, immunoglobulin, and serum—align with these categories, indicating a strategic emphasis on critical care and infectious disease management. The substantial import values of these products underscore their importance in the company's portfolio and their relevance to the healthcare needs of the Philippine population.

2Sourcing Profile

BSV Bioscience Philippines Inc. primarily sources finished pharmaceutical formulations from India, specifically from Bharat Serums and Vaccines Limited. This sourcing strategy reflects a preference for high-quality, ready-to-market products that meet the company's standards for safety and efficacy. The focus on finished formulations, rather than raw Active Pharmaceutical Ingredients (APIs), suggests a streamlined approach to procurement and distribution, ensuring timely availability of essential medicines in the Philippine market.

3Market Positioning

By importing and distributing life-saving and life-enhancing medicines, BSV Bioscience Philippines Inc. serves a critical role in the Philippine healthcare system. Its product mix, which includes essential antifungal treatments and immunoglobulins, positions the company to cater to both hospital and retail pharmacy segments. The widespread use of its products in major hospitals nationwide indicates a strong presence in the institutional healthcare sector, while the availability of these products in retail pharmacies suggests accessibility to the general public.

Seller's Guide — How to Become a Supplier to BSV Bioscience Philippines Inc.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, there is a realistic opportunity to engage with BSV Bioscience Philippines Inc. by offering complementary products that align with the company's therapeutic focus. Identifying gaps in the current product portfolio, such as additional antifungal agents or related critical care medications, could present avenues for collaboration. Demonstrating product quality, regulatory compliance, and a commitment to meeting the specific needs of the Philippine market will be essential in establishing a successful partnership.

2Requirements & Qualifications

Indian exporters seeking to supply BSV Bioscience Philippines Inc. must ensure that their products are registered with the Philippine FDA and comply with the FDA's Good Manufacturing Practice (GMP) standards. Obtaining a valid Certificate of GMP Compliance from the FDA is crucial. Additionally, products must meet the FDA's labeling requirements, including the use of English or Filipino on labels, to facilitate clear communication with healthcare professionals and consumers in the Philippines. (respicio.ph)

3How to Approach

Frequently Asked Questions — BSV Bioscience Philippines Inc.

What products does BSV Bioscience Philippines Inc. import from India?

BSV Bioscience Philippines Inc. imports 3 pharmaceutical products across 2 categories. Top imports: Amphotericin ($450.0K), Immunoglobulin ($250.0K), Serum ($200.0K).

Who supplies pharmaceuticals to BSV Bioscience Philippines Inc. from India?

BSV Bioscience Philippines Inc. sources from 1 verified Indian suppliers. The primary supplier is Bharat Serums And Vaccines Limited (100.0% of imports, $2.2M).

What is BSV Bioscience Philippines Inc.'s total pharmaceutical import value?

BSV Bioscience Philippines Inc.'s total pharmaceutical import value from India is $900.0K, based on 18 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does BSV Bioscience Philippines Inc. focus on?

BSV Bioscience Philippines Inc. imports across 2 categories. The largest: Antifungals (50.0%), Other (50.0%).

Get Full BSV Bioscience Philippines Inc. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.